Access to anti-retroviral drugs, female in France
France: Access to anti-retroviral drugs, female was 93.0% in 2022. ▲ Rising
Access to anti-retroviral drugs, female in France, 2000–2022
Source: UNAIDS estimates. Measured in %.
Analysis
In 2022, access to anti-retroviral drugs, female in France stood at 93.0%. That is the highest value across all 23 years on record.
The figure is up 1.1% on the previous year and up 3.3% over ten years.
Over the whole period, access to anti-retroviral drugs, female in France peaked at 93.0% in 2022 and was at its lowest, 69.0%, in 2000.
That places France 22nd out of 141 countries with data for 2022, putting it in the top quarter.
The long-run direction has been consistently rising across the 23 years of available data.
Access to anti-retroviral drugs, female in France, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 69.0% | — |
| 2001 | 72.0% | +4.3% |
| 2002 | 75.0% | +4.2% |
| 2003 | 79.0% | +5.3% |
| 2004 | 82.0% | +3.8% |
| 2005 | 85.0% | +3.7% |
| 2006 | 86.0% | +1.2% |
| 2007 | 87.0% | +1.2% |
| 2008 | 88.0% | +1.1% |
| 2009 | 89.0% | +1.1% |
| 2010 | 89.0% | +0.0% |
| 2011 | 90.0% | +1.1% |
| 2012 | 90.0% | +0.0% |
| 2013 | 91.0% | +1.1% |
| 2014 | 91.0% | +0.0% |
| 2015 | 92.0% | +1.1% |
| 2016 | 91.0% | -1.1% |
| 2017 | 91.0% | +0.0% |
| 2018 | 89.0% | -2.2% |
| 2019 | 90.0% | +1.1% |
| 2020 | 90.0% | +0.0% |
| 2021 | 92.0% | +2.2% |
| 2022 | 93.0% | +1.1% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 81.2% | 69.0% | 89.0% | 10 |
| 2010s | 90.4% | 89.0% | 92.0% | 10 |
| 2020s | 91.7% | 90.0% | 93.0% | 3 |
Countries ranked near France
- 19 Cameroon 95.0% compare
- 19 Sierra Leone 95.0% compare
- 19 Tajikistan 95.0% compare
- 22 Malawi 93.0% compare
- 22 Morocco 93.0% compare
- 25 Denmark 91.0% compare
- 25 Saudi Arabia 91.0% compare
More gender data for France
- Child population (UN estimates and projections) 10,528 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.9027 % change on previous year (2030)
- Population 58,516 (2030)
- Working-age population (UN estimates and projections) 58,516 (2030)
- Population (UN estimates and projections), annual growth rate 0.327 % change on previous year (2030)
- Age population, age 00, female, interpolated 310,512 (2025)
- Age population, age 00, male, interpolated 325,288 (2025)
- Age population, age 01, female, interpolated 312,212 (2025)
- Age population, age 01, male, interpolated 326,662 (2025)
- Age population, age 02, female, interpolated 325,263 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, female in France?
- Access to anti-retroviral drugs, female in France was 93.0% in 2022, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, female recorded in France?
- The highest recorded value was 93.0% in 2022.
- What is the lowest access to anti-retroviral drugs, female recorded in France?
- The lowest recorded value was 69.0% in 2000.
- How does France rank for access to anti-retroviral drugs, female?
- France ranks 22nd out of 141 countries with data for 2022.
- Is access to anti-retroviral drugs, female rising or falling in France?
- Over the last ten years it is up 3.3%. The long-run trend across the full record is rising.
- Where does this France data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 23 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.